These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7892534)

  • 1. [Ovarian hyperstimulation syndrome].
    de Diego P; Suárez L; Guasch E
    Rev Esp Anestesiol Reanim; 1995 Jan; 42(1):37. PubMed ID: 7892534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Right-sided hydrothorax--the only sign of ovarian hyperstimulation syndrome].
    Mannheimer B; Wramsby M
    Lakartidningen; 2007 Jan 17-23; 104(3):132-3. PubMed ID: 17302118
    [No Abstract]   [Full Text] [Related]  

  • 3. Is 250 microg rHCG always better and safer than 500 microg rHCG?
    Chan CC; Ng EH
    Hum Reprod; 2006 Feb; 21(2):569-70. PubMed ID: 16423839
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the article "Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin].
    Pedroviejo Sáez V
    Rev Esp Anestesiol Reanim; 2010; 57(6):392-3. PubMed ID: 20645497
    [No Abstract]   [Full Text] [Related]  

  • 5. Should we explore OHSS full clinical scope?..
    Kol S
    Hum Reprod; 2001 Mar; 16(3):595-6. PubMed ID: 11228237
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory distress caused by a unilateral hydrothorax as only manifestation of ovarian hyperstimulation syndrome.
    Qublan HS; Barakat M
    J Obstet Gynaecol; 2006 Aug; 26(6):585-6. PubMed ID: 17000522
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro oocyte maturation for safer treatment of infertility. The risk of ovarian overstimulation syndrome is minimized].
    Hreinsson J; Fridström M
    Lakartidningen; 2004 Nov; 101(46):3665-8, 3671. PubMed ID: 15586490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic dysfunction associated with moderate ovarian hyperstimulation syndrome. A case report.
    Elter K; Scoccia B; Nelson LR
    J Reprod Med; 2001 Aug; 46(8):765-8. PubMed ID: 11547654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER; Gómez-Palomares JL; Ricciarelli E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report.
    Rabinerson D; Ben Rafael Z; Keslin J; Zolotarsky V; Dekel A
    J Reprod Med; 2001 Jan; 46(1):68-70. PubMed ID: 11209636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe ovarian hyperstimulation syndrome after exogenous administration of human chorionic gonadotropin].
    Aznar Millán O; Ramos Aparici R; Campos Pérez J; Vila Sánchez M
    Rev Esp Anestesiol Reanim; 2009 Nov; 56(9):565-8. PubMed ID: 20112548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome caused by GnRH-analogue treatment without gonadotropin therapy in a patient with polycystic ovarian syndrome.
    Jirecek S; Nagele F; Huber JC; Wenzl R
    Acta Obstet Gynecol Scand; 1998 Oct; 77(9):940-1. PubMed ID: 9808388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ovarian hyperstimulation syndrome].
    Fukuda J; Shimizu Y; Tanaka T
    Nihon Rinsho; 2006 Jun; Suppl 2():434-7. PubMed ID: 16817436
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline in the prevention of ovarian hyperstimulation syndrome in a rabbit model.
    Serin IS; Ozçelik B; Bekyurek T; Ozturk F; Koc N; Sahin Y
    Gynecol Endocrinol; 2002 Oct; 16(5):355-9. PubMed ID: 12587528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian hyperstimulation syndrome and its therapy].
    Presl J
    Cesk Gynekol; 1980 Sep; 45(8):603-6. PubMed ID: 7428086
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian hyperstimulation syndrome associated with clomiphene citrate.
    Mitchell SY; Fletcher HM; Williams E
    West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships in medicine--causal vs. casual.
    McDonough PG
    Fertil Steril; 1999 Jul; 72(1):190. PubMed ID: 10428181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.